» Articles » PMID: 28752288

Application of Next-generation Sequencing Technology to Diagnosis and Treatment of Focal Segmental Glomerulosclerosis

Overview
Publisher Springer
Specialty Nephrology
Date 2017 Jul 29
PMID 28752288
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

A broad range of genetic and non-genetic factors can lead to kidney injury that manifests as focal segmental glomerulosclerosis (FSGS), which can be classified into primary (idiopathic) and secondary forms. Previous genetic approaches to familial or sporadic cases of FSGS or steroid-resistant nephrotic syndrome identified causal mutations in a subset of genes. Recently, next-generation sequencing (NGS) approaches are becoming a part of a standard assessment in medical genetics. Current knowledge of the comprehensive genomic information is changing the way we think about FSGS and draws attention not only to identification of novel causal genes, but also to potential roles for combinations of mutations in multiple genes, mutations with complex inheritance, and susceptibility genes with variable penetrance carrying relatively minor but significant effects. This review provides an update on recent advances in the genetic analysis of FSGS and highlights the potential as well as the new challenges of NGS for diagnosis and mechanism-based treatment of FSGS.

Citing Articles

A Review of Focal Segmental Glomerulosclerosis Classification With a Focus on Genetic Associations.

Bonilla M, Efe O, Selvaskandan H, Lerma E, Wiegley N Kidney Med. 2024; 6(6):100826.

PMID: 38765809 PMC: 11099322. DOI: 10.1016/j.xkme.2024.100826.


Efficacy of rituximab therapy in children with nephrotic syndrome: a 10-year experience from an Iranian pediatric hospital.

Bazargani B, Noparast Z, Khedmat L, Fahimi D, Esfahani S, Moghtaderi M BMC Pediatr. 2022; 22(1):36.

PMID: 35022016 PMC: 8753871. DOI: 10.1186/s12887-022-03109-4.


Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis.

Park E, Lee C, Kim N, Ahn Y, Park Y, Lee J J Clin Med. 2020; 9(6).

PMID: 32604935 PMC: 7355646. DOI: 10.3390/jcm9062013.


Genetic tests in children with steroid-resistant nephrotic syndrome.

Cheong H Kidney Res Clin Pract. 2020; 39(1):7-16.

PMID: 32155690 PMC: 7105627. DOI: 10.23876/j.krcp.20.001.


Current understandings in treating children with steroid-resistant nephrotic syndrome.

Lee J, Kronbichler A, Shin J, Oh J Pediatr Nephrol. 2020; 36(4):747-761.

PMID: 32086590 PMC: 7910243. DOI: 10.1007/s00467-020-04476-9.


References
1.
Kuusniemi A, Qvist E, Sun Y, Patrakka J, Ronnholm K, Karikoski R . Plasma exchange and retransplantation in recurrent nephrosis of patients with congenital nephrotic syndrome of the Finnish type (NPHS1). Transplantation. 2007; 83(10):1316-23. DOI: 10.1097/01.tp.0000262569.27890.64. View

2.
Beckerman P, Bi-Karchin J, Park A, Qiu C, Dummer P, Soomro I . Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nat Med. 2017; 23(4):429-438. PMC: 5603285. DOI: 10.1038/nm.4287. View

3.
Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, Fenski R . Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet. 2004; 13(21):2625-32. DOI: 10.1093/hmg/ddh284. View

4.
Miyake N, Tsukaguchi H, Koshimizu E, Shono A, Matsunaga S, Shiina M . Biallelic Mutations in Nuclear Pore Complex Subunit NUP107 Cause Early-Childhood-Onset Steroid-Resistant Nephrotic Syndrome. Am J Hum Genet. 2015; 97(4):555-66. PMC: 4596915. DOI: 10.1016/j.ajhg.2015.08.013. View

5.
Weber S, Buscher A, Hagmann H, Liebau M, Heberle C, Ludwig M . Dealing with the incidental finding of secondary variants by the example of SRNS patients undergoing targeted next-generation sequencing. Pediatr Nephrol. 2015; 31(1):73-81. DOI: 10.1007/s00467-015-3167-6. View